New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

Explore Moderna's growth potential with FDA-approved respiratory vaccines, strong cash reserves, and a robust pipeline.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The H5N1 avian flu is circulating in cows and other mammals. Whether it will make a permanent leap to humans is another question ...

This makes the search for the “holy grail” of vaccines, as Sharif puts it, especially pertinent. His lab works on a solution ...